Accelerating research and development of new vaccines against TB: a global roadmap

To eliminate TB globally, new effective and affordable vaccines are needed. Initiated and funded by the European and Developing Countries Clinical Trials Partnership (EDCTP), a Global Roadmap for Research and Development of Tuberculosis Vaccines was developed between September 2019 and February 2021. A review, published in The Lancet Infectious Diseases, listed the actions needed to accelerate the development and implementation of new TB vaccines using a participatory process.